Silva Markovic-Plese Selected Research

Silva Markovic-Plese Research Topics

Disease

22	Relapsing-Remitting Multiple Sclerosis 01/2021 - 05/2004
21	Multiple Sclerosis 01/2022 - 05/2004
6	Demyelinating Diseases (Demyelinating Disease) 12/2018 - 01/2008
5	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2005
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 12/2018
4	Inflammation (Inflammations) 11/2015 - 06/2009
3	Neuroinflammatory Diseases 01/2021 - 03/2008
3	Disease Progression 03/2015 - 04/2005
1	Bites and Stings (Sting) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Cognitive Dysfunction 03/2015
1	Atrophy 03/2015
1	Lymphopenia (Lymphocytopenia) 12/2013
1	HIV Infections (HIV Infection) 06/2011
1	Infections 06/2009
1	Brain Edema (Cerebral Edema) 11/2008
1	Opportunistic Infections (Opportunistic Infection) 11/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2008
1	Alzheimer Disease (Alzheimer's Disease) 03/2008
1	Brain Neoplasms (Brain Tumor) 03/2008
1	Brain Injuries (Brain Injury) 03/2008
1	Virus Diseases (Viral Diseases) 04/2005
1	Paresthesia (Dysesthesia) 04/2005
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 04/2005
1	X-Linked Bulbo-Spinal Atrophy 04/2003

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2021 - 01/2008
4	Monoclonal AntibodiesIBA 01/2022 - 06/2004
4	Interleukin-11 (Interleukin 11)IBA 01/2019 - 06/2015
4	Interferon beta-1a FDA Link 11/2015 - 01/2014
4	AntigensIBA 07/2013 - 04/2005
4	Simvastatin (Zocor)FDA LinkGeneric 01/2013 - 05/2004
4	Interferon-betaIBA 09/2010 - 06/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008 - 09/2006
3	InterferonsIBA 01/2016 - 09/2010
2	VaccinesIBA 01/2021 - 12/2005
2	Interleukin-17 (Interleukin 17)IBA 12/2018 - 01/2008
2	Chemokine CX3CL1IBA 04/2015 - 02/2012
2	Alemtuzumab (Campath)FDA Link 12/2013 - 07/2013
2	AutoantigensIBA 02/2012 - 06/2009
2	Proteins (Proteins, Gene)FDA Link 06/2011 - 04/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2008 - 04/2005
1	Therapeutic UsesIBA 01/2022
1	activin AIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Interleukin-27 (Interleukin 27)IBA 01/2021
1	4-Aminopyridine (4 Aminopyridine)FDA Link 09/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016
1	Interferon Regulatory FactorsIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	Ferritins (Ferritin)IBA 04/2015
1	IronIBA 03/2015
1	GadoliniumIBA 01/2014
1	Myelin-Associated GlycoproteinIBA 09/2012
1	CX3C Chemokine Receptor 1IBA 02/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2011
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2011
1	Interleukin-1 (Interleukin 1)IBA 01/2011
1	Atorvastatin (Lipitor)FDA Link 06/2009
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2009
1	CholesterolIBA 03/2008
1	Coenzyme A (CoA)IBA 09/2006
1	Oxidoreductases (Dehydrogenase)IBA 09/2006
1	Hemagglutinins (Hemagglutinin)IBA 12/2005
1	Peptides (Polypeptides)IBA 12/2005
1	Daclizumab (Zenapax)FDA Link 06/2004
1	Androgen Receptors (Androgen Receptor)IBA 04/2003

Therapy/Procedure

11	Therapeutics 01/2021 - 06/2004
2	Immunomodulation 05/2015 - 04/2011
1	Immunotherapy 01/2021
1	Secondary Prevention 12/2018
1	Highly Active Antiretroviral Therapy (HAART) 11/2008
1	Organ Transplantation 04/2005
1	Liver Transplantation 04/2005